Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
8.21
-0.07 (-0.85%)
Nov 4, 2024, 4:00 PM EST - Market closed

Theravance Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
62.0257.4251.3555.3171.8673.41
Upgrade
Revenue Growth (YoY)
20.97%11.84%-7.17%-23.03%-2.12%21.61%
Upgrade
Cost of Revenue
35.5540.6263.39193.66260.95219.25
Upgrade
Gross Profit
26.4716.8-12.05-138.35-189.1-145.83
Upgrade
Selling, General & Admin
65.4370.167.0799.3108.53106.08
Upgrade
Operating Expenses
65.4370.167.0799.3108.53106.08
Upgrade
Operating Income
-38.96-53.29-79.12-237.64-297.63-251.92
Upgrade
Interest Expense
-2.51-2.35-6.37-8.55-8.55-31.86
Upgrade
Interest & Investment Income
6.149.066.742.014.748.2
Upgrade
Earnings From Equity Investments
-----33.71
Upgrade
Currency Exchange Gain (Loss)
0.060.06-0.9-0.9-0.30.2
Upgrade
Other Non Operating Income (Expenses)
-----1.61-
Upgrade
EBT Excluding Unusual Items
-35.27-46.53-79.65-245.08-303.34-241.68
Upgrade
Merger & Restructuring Charges
--2.74-12.84-20.14--
Upgrade
Gain (Loss) on Sale of Assets
--2.71---
Upgrade
Other Unusual Items
---3.03---
Upgrade
Pretax Income
-38.22-49.27-92.82-265.22-303.34-241.68
Upgrade
Income Tax Expense
7.435.920.01-0.15-8.52-5.22
Upgrade
Earnings From Continuing Operations
-45.65-55.19-92.82-265.07-294.82-236.46
Upgrade
Earnings From Discontinued Operations
--964.9665.6516.81-
Upgrade
Net Income
-45.65-55.19872.13-199.43-278.02-236.46
Upgrade
Net Income to Common
-45.65-55.19872.13-199.43-278.02-236.46
Upgrade
Shares Outstanding (Basic)
505574696256
Upgrade
Shares Outstanding (Diluted)
505574696256
Upgrade
Shares Change (YoY)
-24.30%-24.85%5.95%11.41%12.11%3.04%
Upgrade
EPS (Basic)
-0.92-1.0011.85-2.87-4.46-4.25
Upgrade
EPS (Diluted)
-0.92-1.0011.85-2.87-4.46-4.25
Upgrade
Free Cash Flow
-9.6-29.49-187.56-211.26-257.02-241.37
Upgrade
Free Cash Flow Per Share
-0.19-0.53-2.55-3.04-4.12-4.34
Upgrade
Gross Margin
42.68%29.26%-23.46%-250.12%-263.16%-198.65%
Upgrade
Operating Margin
-62.82%-92.80%-154.09%-429.65%-414.19%-343.14%
Upgrade
Profit Margin
-73.61%-96.11%1698.54%-360.55%-386.90%-322.08%
Upgrade
Free Cash Flow Margin
-15.48%-51.35%-365.29%-381.96%-357.68%-328.78%
Upgrade
EBITDA
-39.18-53.19-76.08-232.83-294-248.93
Upgrade
EBITDA Margin
-63.17%-92.62%-148.18%---
Upgrade
D&A For EBITDA
-0.210.13.044.813.632.99
Upgrade
EBIT
-38.96-53.29-79.12-237.64-297.63-251.92
Upgrade
EBIT Margin
-62.82%-92.80%-154.09%---
Upgrade
Revenue as Reported
62.0257.4251.3555.3171.8673.41
Upgrade
Advertising Expenses
-5.189.36.32.4
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.